Navigation Links
Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results
Date:5/4/2009

NEW BRUNSWICK, N.J., May 4 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") (NYSE Amex: SNT) today reported financial results for the three months ended March 31, 2009.

Net loss for the three month period ended March 31, 2009 was $1,331,477, or $0.07 per share, compared with a net loss of $1,482,217, or $0.08 per share, for the three month period ended March 31, 2008. This decrease in net loss was primarily the result of a decrease in operating expenses, which was partially offset by an increase in non-cash expenses associated with the outstanding convertible notes that were issued during the year ended June 30, 2008.

Quarterly Highlights

As previously reported:

  • Senesco announced results of maximum tolerated dose, preclinical toxicology, and efficacy / dose-range finding studies in mice for SNS-01, the Company's multiple myeloma drug candidate.
  • Management delivered the Company's corporate presentation at the 11th Annual BIO CEO & Investor Conference.

"Senesco's goal continues to be the filing of an Investigational New Drug application for SNS-01, the Company's multiple myeloma drug candidate, before the end of calendar year 2009," said Bruce Galton, President and CEO of Senesco.

Total revenues of $75,000 for the three month period ended March 31, 2009 consisted of a milestone payment on an agricultural license agreement. Total revenues of $79,167 for the three month period ended March 31, 2008 consisted of a milestone payment and the amortized portion of previous milestone payments received in connection with certain agricultural license agreements.

Research and development expenses during the three month period ended March 31, 20
'/>"/>

SOURCE Senesco Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results
2. Senesco and Harris Moran Mutually Agree to Terminate Development and License Agreement Due to Restructuring
3. Senesco Appoints Harlan W. Waksal, M.D., to Board of Directors
4. Senescos Preclinical Multiple Myeloma Data to be Presented at the 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
5. Senesco Technologies Announces Successful Completion of First Milestone Related to Agreement with Bayer CropScience
6. Senesco Technologies Closes Remaining $3.0 Million of Previously Announced Financing
7. Senesco Signs a Supply Agreement for Polyplus-transfections Delivery System
8. Senesco Technologies to Present at BIO 2008 Business Forum
9. Senesco Technologies Reports Third Quarter Fiscal 2008 Financial Results
10. Senesco Technologies Regains Compliance With Amexs Continued Listing Requirements
11. Senesco Technologies Reports Second Quarter Fiscal 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... June 18, 2013 (PRWEB) June 18, 2013 ... and attendance system in North America, has introduced ... employee data and payroll records between ExakTime’s software ... automates ExakTime software setup and keeps employee ... employee data from a business’ current payroll software, ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 Nasseo, Inc. ... Innovation Challenge Winner out of hundreds of applicants by ... spring Arizona Innovation Challenge . The Arizona Innovation ... for a technology commercialization challenge, granting a financial award ... promising technology ventures. Nasseo’s state of the art dental ...
(Date:6/18/2013)... ALBANY, N.Y. , June 18, 2013 /PRNewswire/ ... that its Burlington, Mass. , ... U.S. Drug Enforcement Administration (DEA) registration to handle ... represents the DEA,s acknowledgement of Burlington,s ... inventory control and documentation. (Logo: ...
(Date:6/18/2013)... DUBLIN , June 18, 2013 /PRNewswire/ ... http://www.researchandmarkets.com/research/5g3rx5/dna_sequencing ) has announced the addition of ... Markets and Companies " to their offering. ... This report briefly reviews basics of human ... their applications. Current large and small sequencers ...
Breaking Biology Technology:ExakTime Introduces AccountLinx Plus 2Nasseo Named 2013 Innovation Challenge Winner by Arizona Commerce Authority 2AMRI Burlington Receives DEA Approval to Handle Controlled Substances 2DNA Sequencing: Technologies, Markets and Companies - 2013 Report 2
... -- Third Wave Technologies Inc , a maker ... its Invader 2D6 analysis panel, which provides clinical trial ... assays available for the important 2D6 gene. , ,The ... trial laboratories the ability to configure custom assay panels. ...
... of competing together to race the fastest cars they can ... of 20 engineers, scientists and technicians from Ohio State University ... to win the $1 million dollar grand prize awarded to ... , ,The Defense Advanced Research Projects Agency (DARPA) has a ...
... DNASTAR, Inc . announced today the hiring and appointment ... of the Madison-based bioinformatics company. Schwei has 25 years ... with Promega Corporation, PanVera Corporation and Invitrogen Corporation. ... management and leadership, said Fred Blattner, DNASTARs chief of ...
Cached Biology Technology:Third Wave Releases Gene Test 2Oshkosh Truck Teams with OSU to Compete in DARPA Million Dollar Tech Derby 2Oshkosh Truck Teams with OSU to Compete in DARPA Million Dollar Tech Derby 3
(Date:6/18/2013)... engineer has been awarded a $394,300 grant from ... quality and flow in the new facilities of ... UT Arlington associate professor of civil engineering, will ... monochloramine to the water in an effort to ... and pipelines. Adding monochloramine is widely practiced throughout ...
(Date:6/18/2013)... a very large "dead zone" in the Gulf of ... the Chesapeake Bay this year, based on several NOAA-supported ... Michigan, Louisiana State University, and the Louisiana Universities ... Mexico hypoxic "dead" zone will be between 7,286 and ... ten largest recorded. That would range from an area ...
(Date:6/18/2013)... The National Institutes of Health has awarded $12.7 ... a selection of pharmaceutical industry compounds to explore ... including Alzheimer,s disease, Duchenne muscular dystrophy and schizophrenia. ... Uses for Existing Molecules, is led by the ... funded by the NIH Common Fund. , The ...
Breaking Biology News(10 mins):UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 2NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 3NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 4NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4
... projected this century for Oregon,s Upper Willamette River ... transportation systems, human health, forests, and fish and ... University of Oregon,s Climate Leadership Initiative and the ... The authors say that extensive efforts should begin ...
... the DNA in the nucleus of each of our cells is ... molecules serve as coding templates for the synthesis of proteins. Of ... a scant few are known: they inhibit the activity of genes ... packaged within cells. What the rest of them do within cells ...
... University of Leeds are developing methods of helping contaminated ... such as vinegar. , The harmful chromium compounds ... former textiles factories, smelters, and tanneries have been linked ... with the kidneys, liver, lungs and skin. , The ...
Cached Biology News:Eugene-Springfield face Upper Willamette climate threats 2Eugene-Springfield face Upper Willamette climate threats 3Eugene-Springfield face Upper Willamette climate threats 4CSHL researchers pinpoint structure-building role for 2 non-coding RNAs 2CSHL researchers pinpoint structure-building role for 2 non-coding RNAs 3Cleansing toxic waste -- with vinegar 2
Glucagon-like peptide-1 (GLP-1 (1-36) amide)...
... Early Drug Development with Imaging Mass Spectrometry ... compound localization data in early drug development ... spectrometry service maps unlabeled ions ... you can localize drugs and metabolites prior ...
Best pricing for 100mg-1.0g scales. Phosphopeptides are our specialty....
... The ProteomeLab PF 2D is an ... of complex protein mixtures. Part of ... PF 2D produces results in just hours. ... of proteins present in cell lysates, addressing ...
Biology Products: